[Current guidelines for the treatment of intra-abdominal infections].
Intra-abdominal infections (IAIs) are a frequent cause of mobility and mortality. These infections can be caused by a wide variety of microorganisms, including both aerobes and anaerobes, and are often polymicrobial. Several studies observed that mortality depends on initiating early appropriate antimicrobial therapy. Moreover, the inappropriate choice of initial antibiotic therapy result in a longer hospital stay and higher costs of hospitalization compared with appropriate initial antibiotic therapy. The aim of current review is that of summarize the recommendations of several guidelines on the management of IAIs.
Esposito
Silvano
S
Dipartimento di Malattie Infettive, Seconda Universita di Napoli, Italy.
Carosi
Gianpiero
G
Leone
Sebastiano
S
D034841:Abdominal Cavity / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017281:Cost of Illness; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology*; D004066:Digestive System Diseases / Q000188:drug therapy* / Q000382:microbiology* / Q000401:mortality; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D006760:Hospitalization; D006801:Humans; D007902:Length of Stay; D008826:Microbial Sensitivity Tests / Q000379:methods; D017410:Practice Guidelines as Topic; D013997:Time Factors
D000900:Anti-Bacterial Agents